These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6128698)

  • 1. Pergolide-induced circling in rats with 6-hydroxydopamine lesions in the nigrostriatal pathway.
    Duvoisin RC; Heikkila RE; Manzino L
    Neurology; 1982 Dec; 32(12):1387-91. PubMed ID: 6128698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of pergolide and bromocriptine therapy in parkinsonism.
    LeWitt PA; Ward CD; Larsen TA; Raphaelson MI; Newman RP; Foster N; Dambrosia JM; Calne DB
    Neurology; 1983 Aug; 33(8):1009-14. PubMed ID: 6348585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of three dopamine agonists on cage climbing behavior.
    Gianutsos G; Palmeri JL
    Psychopharmacology (Berl); 1983; 79(4):329-31. PubMed ID: 6134299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pergolide versus bromocriptine.
    Login IS
    Neurology; 1984 Feb; 34(2):258. PubMed ID: 6538025
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative efficacy of pergolide and bromocriptine in patients with advanced Parkinson's disease.
    Lieberman AN; Neophytides A; Leibowitz M; Gopinathan G; Pact V; Walker R; Goodgold A; Goldstein M
    Adv Neurol; 1983; 37():95-108. PubMed ID: 6858782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide.
    Goetz CG; Tanner CM; Glantz RH; Klawans HL
    Neurology; 1985 May; 35(5):749-51. PubMed ID: 3990974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between lergotrile and bromocriptine in parkinsonism.
    Teychenne PF; Pfeiffer RF; Bern SM; McInturff D; Calne DB
    Ann Neurol; 1978 Apr; 3(4):319-24. PubMed ID: 666273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy of two dopamine agonists, pergolide and lergotrile, in Parkinson disease.
    Lieberman AN; Goldstein M; Leibowitz M
    N Y State J Med; 1988 Aug; 88(8):420-2. PubMed ID: 2902541
    [No Abstract]   [Full Text] [Related]  

  • 9. Bromocriptine holiday: effects on dopamine receptors and turning behavior in rats.
    Kenny AM; Schneider MB; Baden DR; Pfeiffer RF; Murrin LC
    Neurology; 1986 Mar; 36(3):400-4. PubMed ID: 3081831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross tolerance between two dopaminergic ergot derivatives--bromocriptine and lergotrile.
    Teychenne PF; Rosin AJ; Plotkin CN; Calne DB
    Br J Clin Pharmacol; 1980 Jan; 9(1):47-50. PubMed ID: 6101955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dopamine D-1 antagonist SCH 23390 inhibits apomorphine but not pergolide induced rotation.
    Herrera-Marschitz M; Hyttel J; Ungerstedt U
    Acta Physiol Scand; 1984 Nov; 122(3):427-8. PubMed ID: 6240190
    [No Abstract]   [Full Text] [Related]  

  • 12. Pergolide in late-stage Parkinson disease.
    Lang AE; Quinn N; Brincat S; Marsden CD; Parkes JD
    Ann Neurol; 1982 Sep; 12(3):243-7. PubMed ID: 6753730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease.
    Schneider MB; Murrin LC; Pfeiffer RF; Deupree JD
    Clin Neuropharmacol; 1984; 7(3):247-57. PubMed ID: 6435870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive supranuclear palsy: clinical features and response to treatment in 16 patients.
    Jackson JA; Jankovic J; Ford J
    Ann Neurol; 1983 Mar; 13(3):273-8. PubMed ID: 6847139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ergot derivatives for Parkinsonism.
    Calne DB; Williams AC; Nutt JG; Neophytides A; Eisler T; Teychenne PF
    Med J Aust; 1978 Nov; 2(3 Suppl):25-6. PubMed ID: 34083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rotational behaviour elicited by intracerebral injections of apomorphine and pergolide in 6-hydroxy-dopamine-lesioned rats. II: The striatum of the rat is heterogeneously organized for rotational behaviour.
    Herrera-Marschitz M; Forster C; Ungerstedt U
    Acta Physiol Scand; 1985 Nov; 125(3):529-35. PubMed ID: 3936339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dopaminergic agonists in Parkinson disease].
    Dubois B; Agid Y
    Rev Prat; 1986 Jan; 36(5):207-14. PubMed ID: 3961400
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of sub-chronic combined treatment with pergolide and caffeine on contralateral rotational behavior in unilateral 6-hydroxydopamine-denervated rats.
    Prat G; Robledo P; Rubio A; Barbanoj M; Jané F; Casas M
    Brain Res; 2000 Jun; 868(2):376-9. PubMed ID: 10854593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rotational behaviour elicited by intracerebral injections of apomorphine and pergolide in 6-hydroxy-dopamine-lesioned rats. I: Comparison between systemic and intrastriatal injections.
    Herrera-Marschitz M; Forster C; Ungerstedt U
    Acta Physiol Scand; 1985 Nov; 125(3):519-27. PubMed ID: 3936338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of repeated administration of dopamine agonists on circling behavior in rats.
    Prikhojan A; Brannan T; Yahr MD
    J Neural Transm (Vienna); 2000; 107(10):1159-64. PubMed ID: 11129105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.